Clinical trial

Effects of Vitamin B6 on the Exercise Pressor Reflex in Lower Limb Ischemia-Reperfusion

Name
STUDY000020217
Description
In this study, we are trying to see if vitamin B6 can minimize the amplified blood pressure response to exercise following ischemia-reperfusion injury. We are interested in a protein called P2X3, of which function can be blocked by vitamin B6, in the neurons of our nervous system. It is very important for blood pressure regulation. We would like to see if the P2X3 plays a role in patients' rising blood pressure during exercise. The results of the proposed studies will provide a base for those two potential economic and non-invasive inventions to improve the overall health and well-being of PAD patients.
Trial arms
Trial start
2024-09-01
Estimated PCD
2025-09-01
Trial end
2025-09-01
Status
Not yet recruiting
Phase
Early phase I
Treatment
Vitamin B6 25 MG
Vitamin B6 25 mg/day will be given for up to 31 days.
Arms:
Vitamin B6 25mg
Vitamin B6 50 MG
Vitamin B6 50 mg/day will be given for up to 31 days.
Arms:
Vitamin B6 50mg
Vitamin B6 100 MG
Vitamin B6 100 mg/day will be given for up to 31 days.
Arms:
Vitamin B6 100mg
Placebo
Placebo capsule will be given for up to 31 days.
Arms:
Placebo
Size
30
Primary endpoint
baseline blood pressure in mmHg
Recorded continuously for up to 4 hours during the study visit
Second visit blood pressure in mmHg
Recorded continuously for up to 4 hours during the second study visit (up to 31 day after the first visit))
baseline heart Rate in beats per minute
Recorded continuously for up to 4 hours during the study visit
Second visit heart Rate in beats per minute
Recorded continuously for up to 4 hours during the second study visit (up to 31 day after the first visit))
baseline muscle sympathetic nerve activity in burst/min
Recorded continuously for up to 4 hours during the study visit
Second visit muscle sympathetic nerve activity in burst/min
Recorded continuously for up to 4 hours during the second study visit (up to 31 day after the first visit))
baseline walking time in minutes
Recording walking time to fatigue (up to 22 minutes maximum) during the study visit
Second visit walking time in minutes
Recording walking time to fatigue (up to 22 minutes maximum) during the second visit (up to 31 days after the first visit))
Eligibility criteria
Inclusion Criteria: * Are males and females at least 21- 70 years of age (inclusive) * Capable of giving informed consent * Are of any race or ethnicity * Can communicate in English * Females may be on oral contraceptives but will be excluded if they are pregnant or lactating * Healthy Status as defined by the absence of evidence of any active or chronic disease as determined by the following: * a detailed medical history * complete physical examination (including vital signs) * a blood pressure that is within a safe range (\<150/100mmHg) Exclusion Criteria: * \< 21 years of age or \> 70 years of age * Pregnant or nursing woman * Prisoners or institutionalized individuals unable to consent * Decisional impairment * Not able to communicate in English. * Current smoker * Have any clinically relevant history or the presence of metabolic (e.g., diabetes), respiratory, renal, hepatic, gastrointestinal, hematological, lymphatic, neurological, cardiovascular, or other disease or diseases that, in the opinion of the research team, exclude the subject from participation. * Presenting with a resting blood pressure of 150/100 or higher * Taking any medications that affect vascular control or autonomic function (e.g. beta blockers, ACE inhibitors, calcium channel blockers, etc.) * Taking a multivitamin with B6, a B-complex vitamin, or vitamin B-6 at baseline, with a history of Parkinson's disease, and taking levodopa * Known allergy or hypersensitivity to Vitamin B6 * Opioid Use Disorder or on opioid therapy * Subject has a recent drug or alcohol abuse history (less than 6 months) or is currently using or abusing excessive alcohol or drugs. Excessive alcohol will be defined as greater than 14 drinks per week. Use of recreational drugs in the past 6 months is also an exclusion.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['EARLY_PHASE1'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'BASIC_SCIENCE', 'maskingInfo': {'masking': 'TRIPLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 30, 'type': 'ESTIMATED'}}
Updated at
2024-04-17

1 organization

1 product

1 drug

2 indications

Product
Vitamin B6